Drug intelligence / Profile preview

Clar Vision

Development stage
Unknown
Lead developer
Iomedae Therapeutics
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

Clar Vision is an oral dietary supplement developed by Iromed Group S.r.l., an Italian ophthalmic company, specifically formulated to support the health of the vitreous body. It is primarily indicated for individuals experiencing vitreous degeneration, commonly manifested as myodesopsia or "eye floaters." The formulation is a combination of proteolytic enzymes, including bromelain and papain, which are intended to aid in the breakdown of collagen aggregates within the vitreous humor. Additionally, it contains a blend of antioxidants such as Vitamin C and Vitamin E, minerals like Zinc, Magnesium, and Potassium, and the amino acid Taurine. These components work synergistically to protect ocular tissues from oxidative stress, maintain electrolyte balance, and support the structural integrity of the connective tissue within the eye.

Brand names
Clar Vision
Other names
Clar Vision dietary supplement

Beyond the preview

Go deeper on Clar Vision.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clar Vision.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call